CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 36 enrolled
Drug / intervention
Desmopressin +1 moredrug
Likely dose
Desmopressin 300μgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00816127
NCT00816127N/ACompleted
CompareCT.gov

Intranasal DDAVP in Preventing Bleeding During Dental Extraction in Cirrhotic Patients

Icahn School of Medicine at Mount Sinai·interventional·Posted Dec 31, 2008·Updated Jan 1, 2009

In Brief

A clinical study evaluating Desmopressin and blood transfusion for Liver Cirrhosis and Coagulopathy. Completed, enrolled 36 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate how effective and cost saving 1-deamino-8-D-arginine vasopressin (desmopressin, DDAVP) is as opposed to the transfusion of blood products in preventing bleeding after teeth extraction in persons with severe liver disease being evaluated for liver transplant.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Cirrhosis, Coagulopathy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 31, 2008
Enrollment StartOct 1, 2003
Primary CompletionMay 1, 2007
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 17.5 years ago

Interventions

Desmopressindrug

intranasal desmopressin (300μg)

blood transfusionbiological

fresh frozen plasma 10ml/kg and/or 1 unit of single donor platelets